title: Drugs with dual-hormone action gain attention in diabetes field.
authors.forename: Veronica
authors.initials: V
authors.lastname: Hackethal
mesh_terms: D040761:Biomimetic Materials / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004704:Endocrinology / Q000379:methods / Q000639:trends*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D054795:Incretins / Q000627:therapeutic use*; D018027:Receptors, Glucagon / Q000819:agonists
chemical_list: C000593833:GLP1R protein, human; D005765:Gastrointestinal Agents; D000067757:Glucagon-Like Peptide-1 Receptor; D007004:Hypoglycemic Agents; D054795:Incretins; D018027:Receptors, Glucagon